EMEA-002383-PIP01-18-M02 - paediatric investigation plan

Glycopyrronium bromide

Key facts

• Active Substance:
  Glycopyrronium bromide
• Therapeutic area:
  Dermatology
• Decision number:
  P/0467/2022
• PIP number:
  EMEA-002383-PIP01-18-M02
• Pharmaceutical form(s):
  Cream
• Condition(s) / indication(s):
  Treatment of hyperhidrosis
• Route(s) of administration:
  Topical use
• Contact for public enquiries:

  Dr. August Wolff GmbH & Co. KG - Arzneimittel

  Email: [e-mail] ; Tel. [phone];

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  17/11/2022

Decision

P/0467/2022 : EMA decision of 17 November 2022 on the acceptance of a modification of an agreed paediatric investigation plan for glycopyrronium bromide (EMEA-002383-PIP01-18-M02)

AdoptedReference Number: EMA/873549/2022